Skip to content

Author

Chan Joon Kim

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Age and antiplatelet de-escalation after myocardial infarction in the TALOS-AMI trial

Abstract Background The clinical effects of dual antiplatelet therapy de-escalation after acute myocardial infarction may differ by age. We evaluated whether the efficacy and safety of de-escalation from ticagrelor to clopidogrel differed by age in stabilized patients after percutaneous coronary intervention (PCI). Pat...

Seonghyeon Bu, Jaehyuk Jang, Sang Hyun Kim et al. · 0 citations
Open access Sep 2026

Clinically suspected familial hypercholesterolemia in acute myocardial infarction: prevalence, prognosis, and angiographic coronary disease extent in a Korean multicenter cohort

Familial hypercholesterolemia (FH) is a well-established risk factor for coronary artery disease (CAD). However, its significance among patients with acute myocardial infarction (AMI) remains incompletely characterized, particularly in East Asia. We analyzed data from a multicenter, retrospective AMI regis...

Kyung An Kim, J. Byeon, Sang Hyun Kim et al. · 0 citations
Open access Aug 2026

Long-term Impact of Residual Inflammatory Risk in Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention Who Achieved Optimal Lipid Control.

BACKGROUND AND OBJECTIVES This study aimed to evaluate the prognostic impact of high residual inflammatory risk (RIR) in patients with acute myocardial infarction (AMI) who underwent percutaneous coronary intervention (PCI) and achieved optimal low-density lipoprotein cholesterol (LDL-C) control. METHODS A retrospect...

Sangho Hyun, Kyung An Kim, Sang Hyun Kim et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.